Replies to post #346 on League of Traders Consortium

[conix]

LinkedIn on CUBT

Dr. Bharti is on the Scientific Advisory Board of Curative Biotechnology (CUBT)





Kapil Bharti • 2nd Translational Scientist | Senior Investigator NIH | Team Leader | Innovator Cell and Gene Therapies, and Vision Research |

This clinical trial for oral metformin as a treatment for Stargardt disease is a perfect example of bench-to-bedside collaboration between my lab Mitra Farnoodian Francesca Barone Ruchi Sharma in my group testing metformin on patient iPSC-RPE and animal models, and my clinician colleague Brian Brooks taking the drug to patients.

We will soon be launching a safety and feasibility trial for AMD with metformin eye drops, a collaboration with Richard Garr at Curative Biotech.

https://www.linkedin.com/feed/update/urn:li:activity:6919657458894258176/